Drug Discovery Market Research Reports & Industry Analysis
Drug discovery is the systematic process of identifying, designing, and developing new pharmaceutical compounds or therapies to treat specific diseases or medical conditions. This is a high-cost, risky business because only a fraction of the therapeutic targets selected for study will yield products that achieve regulatory approval by the Food & Drug Administration (FDA). To help stakeholders navigate this complex market, MarketResearch.com offers a suite of comprehensive drug discovery reports on industries big and small.
Understanding the Drug Discovery Market
- Our compilation of reports features thousands of reports from leading research firms, allowing you to access highly targeted information.
- We provide a rich repository of data, including analysis of drug discovery market trends, forecasts, growth opportunities, and strategies.
- We also provide expert commentary on disruptive technologies and the use of artificial intelligence, machine learning, and blockchain in drug discovery.
Informed Insights: Your Path to Success
Whether you're an industry professional, a consultant, or an executive, our research collection provides credible data to help you make informed decisions that catalyze growth. For decades, we have served top pharmaceutical companies, investment banks, and consulting firms as a trusted research partner. Uncover new opportunities and stay ahead of the curve with MarketResearch.com's drug discovery industry reports.
Drug Discovery Industry Research & Market Reports
-
Female Infertility: Epidemiology Forecast to 2033
... et al., 2009; Mascarenhas et al., 2012; Mayo Clinic, 2021; World Health Organization, 2024). Infertility affects millions of people and has an impact on their families and communities. Estimates suggest that approximately one in every ... Read More
-
Osteoporosis: Seven-Market Drug Forecast and Market Analysis
... as a systemic skeletal disease characterized by low bone mass and micro-architectural deterioration of bone tissue, predisposing a person to bone fragility and susceptibility to fracture. Common sites of fracture include the spine, hip, distal ... Read More
-
Metabolomics: Technologies and Global Markets
... 32 data tables and 39 additional tables An overview of the global market for metabolomics, the study of small molecules, known as metabolites, in cells, biofluids, tissues and organisms Analysis of global market trends, featuring ... Read More
-
Chronic Kidney Disease: Seven-Market Drug Forecast and Market Analysis
... through 2033. GlobalData estimates the sales of CKD therapeutics to be approximately $2.2 billion across the 7MM in 2023. By 2033, GlobalData expects the CKD market to grow at a strong compound annual growth rate ... Read More
-
Global Dysthymia Drugs Market - 2024-2031
... period 2024-2031. Dysthymia is often characterized by chronic depression for at least two years and includes lowered energy, appetite, sleep disturbances and low self-esteem. Anti-depressants are drugs that inhibit the reuptake of neurotransmitters through selective ... Read More
-
Multiple Sclerosis Therapeutics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)
... USD 35.16 billion by 2029, growing at a CAGR of 3.46% during the forecast period (2024-2029). The global multiple sclerosis therapeutics market size is expected to grow from USD 30.03 billion in 2023 to USD ... Read More
-
Niemann Pick Type C: Opportunity Assessment and Forecast - Update
... AGR of 0.29%. Currently, the treatment regimen for NPC in the 3MM is entirely limited to the use of miglustat (Yargesa, Zavesca or generic). There are several unmet needs in this space, including therapies with ... Read More
-
Global Therapeutics Market (2024 Edition): Analysis By Molecule Type (Biologics and Biosimilars, Small Molecules), By Therapeutic Area, By Region, By Country: Market Insights and Forecast (2020-2030)
... titled Global Therapeutics Market (2024 Edition) which provides a complete analysis of the Global Therapeutics industry in terms of market segmentation By Molecule Type (Biologics and Biosimilars, Small Molecules), By Therapeutic Area (Oncology, Infectious Disease, ... Read More
-
United States Endometriosis and Uterine Fibroids Market (2024 Edition): Analysis By Drug Type (GnRH Antagonists, Progesterone, GnRH Agonists and Others), By Route of Administration (Oral and Parenteral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Region, By Country: Market Insights and Forecast (2020-2030)
... Online Pharmacies), By Region, By Country: Market Insights and Forecast (2020-2030) Executive Summary Azoth Analytics has released a research report titled “United States Endometriosis and Uterine Fibroids Market (2024 Edition)” which provides a complete analysis ... Read More
-
Global Neuroblastoma Drugs Market Size study, by Type (Chemotherapy, Immunotherapy, Others), By Route of Administration (Oral, Injectable), By Distribution Channel (Online, Offline), and Regional Forecasts 2022-2032
... million in 2023 and is anticipated to grow with a healthy growth rate of more than 6.2% over the forecast period 2024-2032. Neuroblastoma is a cancer primarily occurring in young children below five years old, ... Read More
-
2024 Global: Narcolepsy Drug Market - Innovative Markets Forecast (2030) report
... 2019 through 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2019 to 2030 using regression ... Read More
-
2024 Global: Narcolepsy Therapeutics Market - Innovative Markets Forecast (2030) report
... 2019 through 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2019 to 2030 using regression ... Read More
-
2024 Global: Lung Cancer Therapeutics Market - Innovative Markets Forecast (2030) report
... the period 2019 through 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2019 to 2030 ... Read More
-
2024 Global: Erectile Dysfunction Drugs - Innovative Markets Forecast (2030) report
... 2019 through 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2019 to 2030 using regression ... Read More
-
Asia Pacific Neuroblastoma Drugs Market Size study, by Type (Chemotherapy, Immunotherapy, Others), By Route of Administration (Oral, Injectable), By Distribution Channel (Online, Offline), and Country Forecasts 2022-2032
... USD 150 million in 2023 and is anticipated to grow with a healthy growth rate of more than 8.08% over the forecast period 2024-2032. Neuroblastoma is a cancer primarily occurred in young children below five ... Read More
-
2024 Global: Metabolomics Market - Innovative Markets Forecast (2030) report
... 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2019 to 2030 using regression analysis in ... Read More
-
2024 Global: Multiple Sclerosis Therapeutics Market - Innovative Markets Forecast (2030) report
... the period 2019 through 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2019 to 2030 ... Read More
-
US Neuroblastoma Drugs Market Size study, by Type (Chemotherapy, Immunotherapy, Others), By Route of Administration (Oral, Injectable), By Distribution Channel (Online, Offline), Forecasts 2022-2032
... 2023 and is anticipated to grow with a healthy growth rate of more than 7.11% over the forecast period 2024-2032. Neuroblastoma is a cancer primarily occurring in young children under five years old, originating in ... Read More
-
Europe Neuroblastoma Drugs Market Size study, by Type (Chemotherapy, Immunotherapy, Others), By Route of Administration (Oral, Injectable), By Distribution Channel (Online, Offline), and Country Forecasts 2022-2032
... million in 2023 and is anticipated to grow with a healthy growth rate of more than 5.96% over the forecast period 2024-2032. Neuroblastoma is a cancer primarily occurred in young children below five years old, ... Read More
-
2024 Global: In-Vitro Lung Model Market - Innovative Markets Forecast (2030) report
... the period 2019 through 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2019 to 2030 ... Read More
-
2024 Global: Immunotherapy Drugs Market - Innovative Markets Forecast (2030) report
... 2019 through 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2019 to 2030 using regression ... Read More
-
2024 Global: Microbiome Therapeutics Market - Innovative Markets Forecast (2030) report
... 2019 through 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2019 to 2030 using regression ... Read More
-
Growth Opportunities in Global Diabetes and Obesity Therapeutics, 2024–2028
... obesity have increased. Since the COVID-19 pandemic, the global prevalence of obesity has worsened. Obesity is considered a main precursor of diabetes and contributes an estimated 80% to 85% toward the risk of type 2 ... Read More
-
Global Neurodegenerative Diseases Therapeutics Market 2024-2028
... neurodegenerative diseases therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current ... Read More
-
Global Autoimmune Hemolytic Anemia Therapeutics Market 2024-2028
... on the autoimmune hemolytic anemia therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis ... Read More
Research Assistance
